← All MEPs

Sara Matthieu

European Parliament · Greens/EFA · 🇧🇪 Belgium

Term: since 8 October 2020

Participation in roll-call votes

91 % of the 2,355 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % October 2020 : participation 63 % (19 / 30), presence 63 % (19 / 30) 2020 November 2020 : participation 100 % (32 / 32), presence 100 % (32 / 32) December 2020 : participation 100 % (30 / 30), presence 100 % (30 / 30) January 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) 2021 February 2021 : participation 100 % (21 / 21), presence 100 % (21 / 21) March 2021 : participation 100 % (31 / 31), presence 100 % (31 / 31) April 2021 : participation 95 % (77 / 81), presence 95 % (77 / 81) May 2021 : participation 100 % (26 / 26), presence 100 % (26 / 26) June 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) July 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) September 2021 : participation 68 % (13 / 19), presence 68 % (13 / 19) October 2021 : participation 100 % (42 / 42), presence 100 % (42 / 42) November 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) December 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) January 2022 : participation 0 % (0 / 7), presence 0 % (0 / 7) 2022 February 2022 : participation 0 % (0 / 29), presence 0 % (0 / 29) March 2022 : participation 0 % (0 / 37), presence 0 % (0 / 37) April 2022 : participation 95 % (21 / 22), presence 95 % (21 / 22) May 2022 : participation 100 % (88 / 88), presence 100 % (88 / 88) June 2022 : participation 100 % (46 / 46), presence 100 % (46 / 46) July 2022 : participation 100 % (31 / 31), presence 100 % (31 / 31) September 2022 : participation 64 % (16 / 25), presence 64 % (16 / 25) October 2022 : participation 100 % (32 / 32), presence 100 % (32 / 32) November 2022 : participation 100 % (38 / 38), presence 100 % (38 / 38) December 2022 : participation 100 % (18 / 18), presence 100 % (18 / 18) January 2023 : participation 100 % (16 / 16), presence 100 % (16 / 16) 2023 February 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) April 2023 : participation 100 % (24 / 24), presence 100 % (24 / 24) May 2023 : participation 100 % (93 / 93), presence 100 % (93 / 93) June 2023 : participation 93 % (37 / 40), presence 93 % (37 / 40) July 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) September 2023 : participation 100 % (27 / 27), presence 100 % (27 / 27) October 2023 : participation 95 % (38 / 40), presence 95 % (38 / 40) November 2023 : participation 100 % (53 / 53), presence 100 % (53 / 53) December 2023 : participation 100 % (40 / 40), presence 100 % (40 / 40) January 2024 : participation 73 % (36 / 49), presence 73 % (36 / 49) 2024 February 2024 : participation 98 % (62 / 63), presence 98 % (62 / 63) March 2024 : participation 100 % (50 / 50), presence 100 % (50 / 50) April 2024 : participation 100 % (213 / 213), presence 100 % (213 / 213) July 2024 : participation 100 % (1 / 1), presence 100 % (1 / 1) September 2024 : participation 100 % (8 / 8), presence 100 % (8 / 8) October 2024 : participation 100 % (13 / 13), presence 100 % (13 / 13) November 2024 : participation 100 % (27 / 27), presence 100 % (27 / 27) December 2024 : participation 100 % (18 / 18), presence 100 % (18 / 18) January 2025 : participation 100 % (6 / 6), presence 100 % (6 / 6) 2025 February 2025 : participation 100 % (10 / 10), presence 100 % (10 / 10) March 2025 : participation 29 % (4 / 14), presence 29 % (4 / 14) April 2025 : participation 100 % (22 / 22), presence 100 % (22 / 22) May 2025 : participation 15 % (8 / 54), presence 15 % (8 / 54) June 2025 : participation 100 % (22 / 22), presence 100 % (22 / 22) July 2025 : participation 100 % (32 / 32), presence 100 % (32 / 32) September 2025 : participation 100 % (29 / 29), presence 100 % (29 / 29) October 2025 : participation 98 % (44 / 45), presence 98 % (44 / 45) November 2025 : participation 78 % (40 / 51), presence 78 % (40 / 51) December 2025 : participation 100 % (31 / 31), presence 100 % (31 / 31) January 2026 : participation 100 % (22 / 22), presence 100 % (22 / 22) 2026 February 2026 : participation 100 % (28 / 28), presence 100 % (28 / 28) March 2026 : participation 100 % (44 / 44), presence 100 % (44 / 44) April 2026 : participation 100 % (51 / 51), presence 100 % (51 / 51) May 2026 : participation 96 % (24 / 25), presence 96 % (24 / 25) June 2026 : participation 97 % (34 / 35), presence 97 % (34 / 35) July 2026 : participation 97 % (34 / 35), presence 97 % (34 / 35) September 2026 : participation 100 % (40 / 40), presence 100 % (40 / 40) October 2026 : participation 100 % (53 / 53), presence 100 % (53 / 53) November 2026 : participation 0 % (0 / 13), presence 0 % (0 / 13)

Their votes

2,355 votes

DateTextResultTheir vote
A statute for European cross-border associations and non-profit organisations Absent
Tackling non-tariff and non-tax barriers in the single market Absent
Corruption and human rights Absent
Human rights and democracy in the world - annual report 2021 Absent
Implementation of the common security and defence policy - annual report 2021 Absent
Implementation of the common foreign and security policy - annual report 2021 Absent
Strengthening Europe in the fight against cancer Absent
Implementation of the Sixth VAT Directive Absent
Assessment of the implementation of Article 50 TEU Absent
A European strategy for offshore renewable energy Absent
Activities of the European Ombudsman - annual report 2020 Absent
European Central Bank – annual report 2021 Absent
Mobilisation of the European Globalisation Adjustment Fund - application EGF/2021/005 FR/AIRBUS - France Absent
Catch documentation programme for bluefin tuna Absent
Acceptance period of vaccination certificates issued in the EU Digital COVID Certificate format indicating the completion of the primary vaccination series Absent
European Maritime, Fisheries and Aquaculture Fund: periods of time and the dates for the inadmissibility of applications for support Absent
Objection pursuant to Rule 112(2) and (3): Genetically modified cotton GHB614 (BCS-GHØØ2-5) Absent
Objection pursuant to Rule 112(2) and (3): Genetically modified soybean GMB151 (BCS-GM151-6) Absent
Impact of national tax reforms on the EU economy Absent
Challenges for urban areas in the post-COVID-19 era Absent
Convention on the Conservation and Management of High Seas Fisheries Resources in the North Pacific Ocean: accession of the European Union Absent
Digital Services Act Absent
Political crisis in Sudan Absent
Situation in Kazakhstan Absent
Violations of fundamental freedoms in Hong Kong Absent
European Medicines Agency Absent
Determining cases where identity data may be considered as same or similar for the purpose of the multiple identity detection pursuant to Regulation (EU) 2019/818 Absent
Determining cases where identity data may be considered as same or similar for the purpose of the multiple identity detection pursuant to Regulation (EU) 2019/817 Absent
The situation in Nicaragua For
Implementation of the Kimberley Process Certification scheme For
Situation at the Ukrainian border and in Russian-occupied territories of Ukraine For
MeToo and harassment – the consequences for the EU institutions For
Fundamental rights and Rule of Law in Slovenia, in particular the delayed nomination of EPPO prosecutors For
Forced labour in the Linglong factory and environmental protests in Serbia For
The situation in Cuba, namely the cases of José Daniel Ferrer, Lady in White Aymara Nieto, Maykel Castillo, Luis Robles, Félix Navarro, Luis Manuel Otero, Reverend Lorenzo Rosales Fajardo, Andy Dunier García and Yunior García Aguilera Against
Continuous crackdown on civil society and human rights defenders in Russia: the case of human rights organisation Memorial For
Deliberations of the Committee on Petitions in 2020 For
Cooperation on the fight against organised crime in the Western Balkans Abstention
New orientations for the EU’s humanitarian action For
Transitional provisions for certain in vitro diagnostic medical devices and deferred application of requirements for in-house devices For

Rows per page: 20 40 100 200 All